One study reported that the RS19 test is a new blood-based methylation assay for early gastric cancer detection that combines two methylated genes (RNF180 and SEPT9) in a single reaction to improve the rate for early-stage gastric cancer and gastric dysplasia detection14. This evidence concerns the gene SEPTIN9 and gastric cancer.